Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center

Jason D. Robinson, Maher Karam-Hage, George Kypriotakis, Diane Beneventi, Janice A. Blalock, Yong Cui, Roberto Gonzalez, Jean Tayar, Patrick Chaftari, Paul M. Cinciripini

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science